NRx Pharmaceuticals Initiates Phase 3 Trial Treating Patients with Bipolar Depression with Acute Suicidality

First investigational drug for patients with Severe Bipolar Depression and Acute Suicidal Ideation/Behavior, a high unmet medical need Company received...

Related Keywords

United States ,Americans ,America ,Stephen Willard ,Suzanne Messere ,Molly Cogan ,Global Communications ,Company Phase ,Prnewswire Nrx Pharmaceuticals Inc ,Nrx Pharmaceuticals Inc ,Nrx Pharmaceuticals ,Nasdaq ,Psychiatry Division ,Government Affairs ,Nrxp Nrx Pharmaceuticals ,Severe Bipolar Depression ,Acute Suicidal ,Breakthrough Therapy Designation ,Special Protocol Assessment ,Acute Suicidal Ideation ,Healthcare Conference ,Protocol Agreement ,Sub Acute Suicidality ,Special Protocol Agreement ,Securities Litigation Reform Act ,Nc ,